Navigation Links
AcelRx Pharmaceuticals Reports Second Quarter 2013 Financial Results
Date:8/12/2013

REDWOOD CITY, Calif., Aug. 12, 2013 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), ("AcelRx"), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, today reported financial results for the three and six months ended June 30, 2013.

"With the successful completion of our Zalviso™ clinical program that includes data from all three Phase 3 studies, each of which met its primary endpoint, we are preparing to submit our New Drug Application (NDA), by the end of the third quarter," stated Richard King, president and CEO of AcelRx.  "We were pleased with the financing completed last month in which we raised almost $48 million in net proceeds.  This additional cash provides the resources to fund operations at least through the end of 2014 including commercial preparation activities for, and the potential launch of, Zalviso in the United States."

Second Quarter Financial ResultsNet loss for the second quarter of 2013 was $17.4 million, or $0.47 per share, compared with a net loss of $7.2 million, or $0.35 per share for the second quarter of 2012.  Adjusted net loss for the second quarter of 2013 was $8.1 million, or $0.22 per share and excludes the $9.3 million non-cash expense resulting from the liability accounting related to warrants issued in connection with the PIPE financing completed in June 2012. There was no such expense recorded in the second quarter of 2012.

During the second quarters of 2013 and 2012, AcelRx recognized revenue of $407,000 and $224,000, respectively, as reimbursement for work completed under a research grant from the U.S. Army Medical Research and Materiel Command (USAMRMC), for development of ARX-04, a sufentanil NanoTab pro
'/>"/>

SOURCE AcelRx Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. AcelRx Pharmaceuticals to Present at Canaccord Genuity 33rd Annual Growth Conference
2. AcelRx Pharmaceuticals to Hold Second Quarter 2013 Financial Results Conference Call and Webcast on August 12, 2013
3. AcelRx Pharmaceuticals Announces Closing Of Public Offering And Exercise Of Option To Purchase Additional Shares
4. AcelRx Pharmaceuticals to Host Investor Day on June 27, 2013
5. AcelRx Pharmaceuticals to Present at the UBS Global Healthcare Conference
6. AcelRx Pharmaceuticals Reports First Quarter 2013 Financial Results
7. AcelRx Pharmaceuticals to Hold First Quarter 2013 Financial Results Conference Call and Webcast on May 8, 2013
8. AcelRx Pharmaceuticals Presents Positive Clinical Data for the Sufentanil NanoTab PCA System at ASRA Medical Meeting
9. Top-line Data Show AcelRx Pharmaceuticals ARX-04 Achieves Primary Endpoint in Dose-Finding Phase 2 Clinical Trial
10. AcelRx Pharmaceuticals Reports Fourth Quarter and Full-Year 2012 Financial Results
11. AcelRx Pharmaceuticals to Hold Fourth Quarter 2012 Financial Results Conference Call and Webcast on March 12, 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/3/2015)... -- GenVec, Inc. (NASDAQ: GNVC ) today announced a ... and his team from the School of Medicine at ... (WUSTL).  Dr. Curiel is the director of the Biologic ... Department of Radiation Oncology. Under the ... versions of GenVec,s gorilla adenovectors that incorporate specialized targeting ...
(Date:6/3/2015)... June 3, 2015  Armetheon, Inc., a specialty ... cardiovascular diseases, today announced that Sanjay Kakkar ... Executive Officer, effective immediately. Dr. Kakkar brings more ... enterprises, with a successful track record in advancing ... With expertise that includes the development of novel ...
(Date:6/3/2015)... June 02, 2015 Research and Markets ( ... "Europe CT Market - Growth, Trends And Forecasts (2014 ... Computed tomography (CT) is an imaging process that customs ... images, or scans, of areas inside the body. It ... (CAT) scanning. It is primarily used in the Cancer ...
Breaking Medicine Technology:GenVec And Washington University at St. Louis Form Collaboration To Discover Targeted Adenovector-Based Therapeutics And Vaccines 2GenVec And Washington University at St. Louis Form Collaboration To Discover Targeted Adenovector-Based Therapeutics And Vaccines 3GenVec And Washington University at St. Louis Form Collaboration To Discover Targeted Adenovector-Based Therapeutics And Vaccines 4Armetheon Names Dr. Sanjay Kakkar as Chief Executive Officer 2Armetheon Names Dr. Sanjay Kakkar as Chief Executive Officer 3Armetheon Names Dr. Sanjay Kakkar as Chief Executive Officer 4Europe CT Market Report 2015-2019 - Growth, Trends And Forecasts 2
... July 1 Caraco Pharmaceutical Laboratories, Ltd. (NYSE ... capsules. These products, approved by the US Food and ... Application (ANDA), are therapeutically equivalent to Exelon® capsules from ... to moderate Alzheimer,s dementia and mild to moderate Parkinson,s ...
... BEIJING , July 1 /PRNewswire-Asia-FirstCall/ ... the development, assembly, marketing and,sale of medical devices and homecare medical products ... Financial Officer, and Sam Shuguang Gui, Vice,President of Strategic Development, will present ... San Francisco, CA. , , ...
Cached Medicine Technology:Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Exelon® Capsules 2Dehaier Medical Systems to Present to Investors at Global Hunter Securities 2010 China Investor Conference in San Francisco 2Dehaier Medical Systems to Present to Investors at Global Hunter Securities 2010 China Investor Conference in San Francisco 3
(Date:6/3/2015)... (PRWEB) June 03, 2015 Peter Piot, ... Award at DIA’s upcoming Annual Meeting. DIA’s Global Inspire ... leadership, level of excellence, and commitment to service on ... the President’s Award for Outstanding Contribution to Global Health ... contributions to advancing global health. , “DIA ...
(Date:6/3/2015)... FL (PRWEB) June 03, 2015 For the ... LLC, ( http://myclassifiedads.net ), a full-service advertising agency, has been ... Tampa Chamber of Commerce. , MCA has been selected as ... Awards. The company will be honored at a luncheon sponsored ... at the Tampa Museum of Art. , “This luncheon will ...
(Date:6/3/2015)... Fourroux Prosthetics, located at 6630 McGinnis Ferry Rd, ... opening with a ribbon cutting ceremony on Wednesday, June ... kind in the area, Fourroux Prosthetics will provide amputee ... use of patented advanced prosthetics CAD/CAM technology. ... states, “Our goal has always been to provide amputees ...
(Date:6/3/2015)... Scanalytics ” was featured on NewsWatch as part of ... coolest technology products available to consumers. Andrew Tropeano, a ... review and shared with viewers how this technology allows ... Tracking statistics in business is invaluable in analyzing and ... goes a step beyond revenue statistics and tracking how ...
(Date:6/3/2015)... (PRWEB) June 03, 2015 Veatch Consulting ... Satisfaction. Since they first opened for business in April ... service the needs of their clients. Each and every ... Veatch Dental Consulting is proud to say that they ... , A new feature recently added this year is ...
Breaking Medicine News(10 mins):Health News:Co-discoverer of Ebola Virus and AIDS Pioneer to be Honored with Global Inspire Award at DIA’s 2015 51st Annual Meeting 2Health News:Co-discoverer of Ebola Virus and AIDS Pioneer to be Honored with Global Inspire Award at DIA’s 2015 51st Annual Meeting 3Health News:My Classified Ads Has Been Selected as a Semi-Finalist for the 2015 ‘Small Business of the Year’ Awards 2Health News:My Classified Ads Has Been Selected as a Semi-Finalist for the 2015 ‘Small Business of the Year’ Awards 3Health News:Fourroux Prosthetics Atlanta to Have Grand Opening Gala & Ribbon Cutting Ceremony 2Health News:Technology to Analyze Foot Traffic in Retail Stores was featured on NewsWatch Television 2Health News:Veatch Consulting Services Is Breaking New Ground in Customer Satisfaction 2Health News:Veatch Consulting Services Is Breaking New Ground in Customer Satisfaction 3
... two thirds of the Britons fearing heart attacks are willing ... reluctance in calling emergency help have proved to be fatal ... biggest killer, often killing at least one in every five ... was conducted under the BHF's 'Doubt Kills' campaign aiming at ...
... is used to treat bleeding disorders, like hemophilia, is being ... Iraq. // ,The drug Recombinant Activated Factor VIII has ... non-hemophiliacs. It can cause heart attacks, and strokes due to ... effects, continue to prescribe it to control life threatening blood ...
... Southwester Medical Center, children who were treated successfully for leukemia ... in life. // ,In addition, childhood cancer survivors who ... cancer showed even greater risk of stroke in later life, ... issue of the Journal of Clinical Oncology and is available ...
... studies have dug out evidence that link cancer to ... the studies conducted by scientists from University of California, ... have lesser chances of contracting ovarian cancer. Their study, ... that more exposure of sunlight will result in more ...
... of Norovirus has been reported in Royal Bournemouth Hospital. The ... 4,5,27 // and 28 to visitors. Hospital authorities have confirmed ... It does not pose any threat to other departments especially ... of kin are permitted to visit patients in the hospital ...
... near, the hunt is on for parents to find the ... toys and games are available, Anne Mejia Downs // , ... urges parents to look specifically for toys and games that ... the country, toys that get kids moving are some of ...
Cached Medicine News:Health News:Childhood Survivors Of Brain Tumors More At Risk For Strokes Later In Life 2Health News:Childhood Survivors Of Brain Tumors More At Risk For Strokes Later In Life 3Health News:Buy Children Holiday Gifts That Encourage Physical Activity 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: